Cell Signaling Technology

CST is a private, family-owned company, founded by scientists and dedicated to providing high-quality research tools.

[Cell Signaling Technology @CellSignal]

🔀 A *twist* of fate in tumor evolution? When EMT drivers like TWIST, ZEB1, and Snail rewire cellular identity, cancer cells can gain phenotypic plasticity.

👉 Explore key EMT signatures, pluripotency markers, and “stemness” targets on the #CSTBlog.
https://t.co/LWYRTjES6T

[Cell Signaling Technology @CellSignal]

Inflammasome Therapeutics: How the Inflammasome Pathway is Being Targeted to Treat Chronic Diseases - Explore how targeting inflammasome pathways leads to novel therapeutics for chronic diseases on the CST Blog.
https://t.co/HJxuKpyvWo

[Cell Signaling Technology @CellSignal]

Do you want publication-ready IHC/IF images every time? Join us for our live Applications 101 webinar, See the Signal: Master IHC & IF Staining.

Get practical tips and tricks for successful imaging results

📅 Oct 29 | 8:00 AM & 4:00 PM CET 
👉 Register: https://t.co/InNlYv8P5Q

[Cell Signaling Technology @CellSignal]

Huntington's Disease Biomarkers: Key Molecular Targets and Antibody Tools for HD Research - Explore key Huntington's disease biomarkers and validated CST antibodies for studying mHTT, neuronal loss, striatal dysfunction, and neuroinflammation.
https://t.co/TbErv8p9UE

[Cell Signaling Technology @CellSignal]

#ELRIGDD26 #DrugDiscovery #SpatialBiology

[Cell Signaling Technology @CellSignal]

Discover how CST chimeric monoclonal antibodies enable low-plex, multi-species imaging of brain cell markers with greater panel flexibility. 

📆 14-15 October |
⏰ 13:30 - 14:00 | 🖼️ Poster #238

Visit our poster at ELRIG Drug Discovery 2026!

[Cell Signaling Technology @CellSignal]

🧬🔬Trying to identify the epigenetic reprogramming mechanism responsible for the change in gene expression? Analyze epigenetic regulator proteins via chromatin profiling to identify changes in epigenetic signatures across the genome.
https://t.co/Aov2oO9EDO

[Cell Signaling Technology @CellSignal]

A “pan” western blot-validated antibody might not give you the IHC coverage you need. Learn how our new Pan-Keratin MultiMab® Antibody mix, validated in both applications, enables confident ID of epithelial and tumor cells in your tissue samples.
https://t.co/N85u0I0o3C

[Cell Signaling Technology @CellSignal]

Heading to #ELRIGDD26 next week? 

Explore CST solutions for spatial biology, immunoassays & antibody conjugation—including SignalStar® Multiplex IHC, chimeric antibodies and validated antibody pairs built for data you can trust. 

#DrugDiscovery #SpatialBiology

[Cell Signaling Technology @CellSignal]

🏗️🩸Why is tumor vasculature chaotic, disorganized, and characteristically leaky?

👉 Explore the signaling events behind the “angiogenic switch” including markers from key pathways that are activated as part of tumor angiogenesis.
https://t.co/KiINmbTF4J

[Cell Signaling Technology @CellSignal]

How the Inflammasome Drives Disease: Tackling Aberrant Inflammasome Signaling - Discover how aberrant inflammasome signaling drives chronic disease and explore CST-validated antibodies to study these non-communicable pathways.
https://t.co/Iaq4febI0s

[Cell Signaling Technology @CellSignal]

Identifying key drivers of sustained cellular proliferation is now possible at the single-cell level 📈

InTraSeq™ Single Cell Analysis conjugate antibody cocktails contain key cell growth and viability signaling targets: https://t.co/zSJF1KkZPj

[Cell Signaling Technology @CellSignal]

Inconsistent ELISA results? Join Dr Christina Theisgen for our live Applications 101 webinar and learn how to build more reliable assays with ELISA kits and matched antibody pairs.
📅 Oct 1 | 8:00 AM & 4:00 PM CEST
👉 Register: https://t.co/cN0AzH9sL4

[Cell Signaling Technology @CellSignal]

EMT is an example of phenotypic plasticity driven by dedifferentiation that can facilitate cancer progression

Use CST® IHC-validated antibodies against E-Cadherin and N-Cadherin to determine if the cadherin switch has been activated in your cancer model
https://t.co/A3hnM18ACp

[Cell Signaling Technology @CellSignal]

An Open Letter Concerning Antibody Data Integrity - Open Letter to the Scientific Community | CST Commitment to Data Integrity
https://t.co/2uq2YORCs9

[Cell Signaling Technology @CellSignal]

Why We Have 13,500 Antibodies, Not >100K | Manufacturing Transparency
https://t.co/KMeH47YkYf

[Cell Signaling Technology @CellSignal]

CST® antibodies against key autophagy targets like LC3A/B, as well as antibody sampler kits, support researchers studying the rewiring of metabolic pathways within cancer cells: https://t.co/mhihgGFd0s

[Cell Signaling Technology @CellSignal]

Understanding how autophagy is contributing to the progression of a tumor is another aspect of Deregulating Cellular Metabolism ⚛️

[Cell Signaling Technology @CellSignal]

New Webinar Series: Master core lab techniques with CST experts 

● Oct 1 – ELISA 
● Oct 29 – IHC/IF 
● Dec 3 – Flow Cytometry 
● Jan 21 – Western Blotting 

Register today: https://t.co/ivKdij7s2c

[Cell Signaling Technology @CellSignal]

⚡🔬Planning your next experiment to examine cancer metabolism? Start with the pathways tumors most commonly hijack.

🔗 Explore key metabolic signaling targets, pathways, and antibody tools for Deregulating Cellular Metabolism on the #CSTBlog.
https://t.co/9aweCUWTZz